BridgeBio Oncology Therapeutics, Inc.
BBOT
$11.38
$0.312.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 256.39% | -3.18% | -- | ||
| Total Receivables | -79.02% | 2,592.50% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 74.56% | 60.90% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | 92.24% | -- | ||
| Total Current Assets | 234.40% | 0.72% | -- | ||
|
|
|||||
| Total Current Assets | 234.40% | 0.72% | -- | ||
| Net Property, Plant & Equipment | -5.28% | 2.68% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 1.06% | 6.00% | -- | ||
| Total Assets | 220.52% | 0.95% | -- | ||
|
|
|||||
| Total Accounts Payable | 66.14% | -39.86% | -- | ||
| Total Accrued Expenses | 26.48% | 51.80% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 58.13% | 5,233.33% | -- | ||
| Total Finance Division Other Current Liabilities | 109.39% | -92.36% | -- | ||
| Total Other Current Liabilities | 109.39% | -92.36% | -- | ||
| Total Current Liabilities | 31.05% | 13.28% | -- | ||
|
|
|||||
| Total Current Liabilities | 31.05% | 13.28% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -5.29% | -4.88% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 27.98% | 11.48% | -- | ||
|
|
|||||
| Common Stock & APIC | 1,590.14% | 1.97% | -- | ||
| Retained Earnings | -16.39% | -11.63% | -- | ||
| Treasury Stock & Other | -29.41% | -73.30% | -- | ||
| Total Common Equity | 296.15% | -13.85% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 8.06% | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 8.06% | -- | ||
|
|
|||||
| Total Common Equity | 296.15% | -13.85% | -- | ||
| Total Preferred Equity | -- | 8.06% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 267.69% | -1.34% | -- | ||
|
|
|||||